Deep Track Capital, LP - 31 Dec 2025 SCHEDULE 13G/A Report for Akero Therapeutics, Inc. Common Stock, par value $0.0001 per share (AKRO)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Akero Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
AKRO
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 08:41:34 UTC
Date of event
31 Dec 2025
Previous filing
07 Oct 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Deep Track Capital, LP disclosed 0% ownership in Akero Therapeutics, Inc. Common Stock, par value $0.0001 per share (AKRO) on 31 Dec 2025."

Quick Takeaways

  • Deep Track Capital, LP filed SCHEDULE 13G/A for Akero Therapeutics, Inc. Common Stock, par value $0.0001 per share (AKRO).
  • Disclosed ownership: 0%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 07 Oct 2025.
  • Current filing was accepted on 13 Feb 2026, 08:41.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 0% 0 0 0 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 0% 0 0 0 /s/ David Kroin David Kroin, Director
David Kroin 0% 0 0 0 /s/ David Kroin David Kroin

Sponsored